Detalles de la búsqueda
1.
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results.
Br J Haematol
; 180(6): 821-830, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29435979
2.
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.
Lancet Oncol
; 18(2): 241-250, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27956157
3.
A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide-containing regimens.
Br J Haematol
; 176(3): 440-447, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27859001
4.
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib.
Blood
; 125(16): 2497-506, 2015 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-25700432
5.
Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
Br J Haematol
; 171(1): 52-9, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26018491
6.
Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib.
Blood
; 121(11): 1961-7, 2013 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-23243282
7.
Steroid-associated side effects in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.
Clin J Oncol Nurs
; 12(3 Suppl): 53-63, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18490257
8.
Management of side effects of novel therapies for multiple myeloma: consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board.
Clin J Oncol Nurs
; 12(3 Suppl): 9-12, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18490252
9.
Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review.
Lancet Haematol
; 5(7): e299-e309, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29958569
10.
Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma.
Leuk Lymphoma
; 59(11): 2588-2594, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29616843
11.
Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Clin Cancer Res
; 23(5): 1149-1155, 2017 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28073846
12.
Vorinostat in Combination With Lenalidomide and Dexamethasone in Lenalidomide-Refractory Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 16(10): 558-562, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27769558
13.
Carfilzomib: a next-generation proteasome inhibitor for multiple myeloma treatment.
Clin J Oncol Nurs
; 17(2): E35-44, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23538263
14.
Novel agents for the treatment of multiple myeloma: proteasome inhibitors and immunomodulatory agents.
J Adv Pract Oncol
; 4(5): 307-21, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25032010
15.
Extended follow-up with the Bruton's tyrosine kinase inhibitor ibrutinib in previously treated Waldenström's macroglobulinemia.
Leuk Lymphoma
; 58(6): 1502-1505, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27784188
16.
Phase II trial of syncopated thalidomide, lenalidomide, and weekly dexamethasone in patients with newly diagnosed multiple myeloma.
Clin Lymphoma Myeloma Leuk
; 12(3): 186-90, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22381702
17.
Routine health maintenance in patients living with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.
Clin J Oncol Nurs
; 15 Suppl: 25-40, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21816708
18.
Survivorship care guidelines for patients living with multiple myeloma: consensus statements of the International Myeloma Foundation Nurse Leadership Board.
Clin J Oncol Nurs
; 15 Suppl: 5-8, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21816706
19.
The anion gap and routine serum protein measurements in monoclonal gammopathies.
Clin J Am Soc Nephrol
; 6(12): 2814-21, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22157711
Resultados
1 -
19
de 19
1
Próxima >
>>